NasdaqHealth CareSurgical & Medical Instruments & ApparatusKIRKLAND, WA

Kestra Medical Technologies, Ltd. KMTS

Ask your AI

Estimated market cap $1.71B59.56M shares, shares as of Sep 11, 2026CIK 1877184

Insider trades, 12 mo

1 buy · 53 sells

$15.44M sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

28.4% of shares · 30 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Kestra Medical Technologies, Ltd.'s latest quarterly report, compared with the one before.

Filed Sep 14, 2026 · Quarter ended Jul 31, 2026

Compared with the 10-K for the period ended Apr 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Kestra Medical Technologies, Ltd.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

54 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Recent insider trades

Timothy P. Moran Chief Business Officer	Nov 3 Form 4 ↗	Sale	−$94.4K 3,192 sh @ $29.56	-1.3%
Vaseem Mahboob Chief Financial Officer	Oct 29 Form 4 ↗	Sale 10b5-1 plan	−$146.5K 4,788 sh @ $30.60	-4.5%
Vaseem Mahboob Chief Financial Officer	Oct 28 Form 4 ↗	Sale 10b5-1 plan	−$1.2M 39,903 sh @ $30.48	-1.8%
Vaseem Mahboob Chief Financial Officer	Oct 27 Form 4 ↗	Sale 10b5-1 plan	−$1.0M 34,809 sh @ $30.04	-2.5%
Traci S. Umberger See Remarks, Director	Oct 27 Form 4 ↗	Sale 10b5-1 plan	−$900.9K 30,000 sh @ $30.03	-2.5%

All KMTS insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

16.90M shares

73 funds report KMTS. Values checked against market prices.

Funds report more than 100% of shares (Q2 2026)

109 funds hold the stock.

Q3 2026: 28% · 5,560 of ~8,900 funds reported so far

Q2 202592%
Q3 202594%
Q4 202596%
Q1 2026>100%
Q2 2026>100%
Q3 2026 (so far)28%

Q3 2026. 11 new, 30 added to, 16 trimmed, 47 exited since Q2 2026.

Top 13F holders
#
1	FMR LLC 13F ↗	5.96M	$168.5M	+7.9%
2	BlackRock, Inc. 13F ↗	2.23M	$63.1M	+19.6%
3	Vanguard Capital Management LLC 13F ↗	1.33M	$37.6M	+13.1%
4	Eventide Asset Management, LLC 13F ↗	1.26M	$35.6M	-13.0%
5	Franklin Templeton Inc 13F ↗	989,054	$30.2M	-12.0%
6	Geode Capital Management, LLC 13F ↗	794,898	$22.5M	+22.8%
7	State Street Corp 13F ↗	779,200	$22.0M	+4.2%
8	Federated Hermes, Inc. 13F ↗	615,000	$17.4M	+17.1%
9	Next Century Growth Investors LLC 13F ↗	444,075	$12.6M	-3.1%
10	UBS Group AG 13F ↗	353,024	$10.0M	+8.3%

Download CSV Every fund that holds KMTS, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Kestra Medical Technologies, Ltd. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Kestra Medical Technologies, Ltd. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q1 2025	63	—	44.84M	$1.1B
Q2 2025	73	+10	47.38M	$785.5M
Q3 2025	80	+7	48.41M	$1.2B
Q4 2025	107	+27	56.15M	$1.5B
Q1 2026	103	-4	58.43M	$1.2B
Q2 2026	109	+6	58.73M	$1.5B
Q3 2026	73	-36	16.90M	$480.5M

Each point is a quarter-end, from Q1 2025 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (G52441105). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2025) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes5 in 12 mo 8-K events2 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesForm 144 · 43 in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials1 active FDA decisionsLatest Mar 6 IPO history2 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: KESTRA MEDICAL TECHNOLOGIES, LTD.
Address: 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND, WA 98033
Phone: (425) 279-8002
Fiscal year ends: Apr 30
Filer category: Non-accelerated filer, smaller reporting company, emerging growth company
Incorporated in: Bermuda
Listed as: KMTS (Nasdaq)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$28.64+$0.02 (+0.07%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $25.47 · High $31.63Nov 13, 2026

Aug 13, 2026Low $22.85 · High $31.63Nov 13, 2026

Nov 13, 2025Low $17.87 · High $31.63Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.